These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9240663)

  • 21. The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease.
    Paschou SA; Palioura E; Kothonas F; Myroforidis A; Loi V; Poulou A; Goumas K; Effraimidis G; Vryonidou A
    Endocr J; 2018 Nov; 65(11):1121-1125. PubMed ID: 30135331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
    Sherman M; Tsynman DN; Kim A; Arora J; Pietras T; Messing S; St Hilaire L; Yoon S; Decross A; Shah A; Saubermann L
    J Dig Dis; 2014 Apr; 15(4):174-9. PubMed ID: 24373601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conservative therapy of inflammatory bowel diseases].
    Nagy F
    Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative tolerability of treatments for inflammatory bowel disease.
    Stein RB; Hanauer SB
    Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the drug treatment regimens for inflammatory bowel disease.
    Brock EM; Zabihollah M
    Expert Opin Pharmacother; 1999 Nov; 1(1):15-8. PubMed ID: 11249558
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aminosalicylates in the treatment of idiopathic inflammatory bowel disease].
    Lukás K
    Vnitr Lek; 1996 Feb; 42(2):117-9. PubMed ID: 8686186
    [No Abstract]   [Full Text] [Related]  

  • 28. How safe are the safest IBD drugs?
    Lewis JD
    Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in inflammatory bowel disease.
    Hunter J
    Br J Hosp Med (Lond); 2007 Jul; 68(7):350. PubMed ID: 17663303
    [No Abstract]   [Full Text] [Related]  

  • 30. Medical therapy of inflammatory bowel disease.
    Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):xv-xvi. PubMed ID: 15177548
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 32. Inflammatory bowel disorders. Summary and table.
    Wagetaff A; Elkinson S
    Drugs R D; 1999 Mar; 1(3):245-50. PubMed ID: 10566036
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of radiation-induced colitis with sucralfate enemas].
    del Val Antoñana A; López Serrano A; Ortiz Polo I; Moreno-Osset E
    Rev Esp Enferm Dig; 2002 Jul; 94(7):439-40. PubMed ID: 12432844
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):157-9. PubMed ID: 16469674
    [No Abstract]   [Full Text] [Related]  

  • 35. Mesalazine preparations.
    Forbes A; Chadwick C
    Lancet; 1997 Nov; 350(9087):1329. PubMed ID: 9357436
    [No Abstract]   [Full Text] [Related]  

  • 36. Managing the glucocorticoid dependent inflammatory bowel disease patient.
    Bonner GF
    Semin Gastrointest Dis; 2001 Oct; 12(4):237-44. PubMed ID: 11726077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.
    Danese S; Fiorino G; Raine T; Ferrante M; Kemp K; Kierkus J; Lakatos PL; Mantzaris G; van der Woude J; Panes J; Peyrin-Biroulet L
    J Crohns Colitis; 2017 Jan; 11(1):26-34. PubMed ID: 27927718
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide.
    American Gastroenterological Association
    Gastroenterology; 2017 Sep; 153(3):860-861. PubMed ID: 28774545
    [No Abstract]   [Full Text] [Related]  

  • 39. Lowering the stress of inflammatory bowel disease.
    Giallourakis C
    Inflamm Bowel Dis; 2002 Sep; 8(5):370-1. PubMed ID: 12479654
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of preoperative biological therapy on complications after abdominal surgery for inflammatory bowel disease.
    Yamamoto T; Shiraki M
    Gut; 2013 Mar; 62(3):475-6. PubMed ID: 22842617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.